From the publishers of JADPRO
CAR T-Cell Therapy
Resource Center
Menu
Resources
Videos
Videos
Fast Facts
Quizzes
News & Literature Highlights
Case Studies
Advertisement
Test your knowledge on CAR T-cell products
Last Updated: Friday, June 16, 2023
Fast Facts #8: Current Commerical Products
Loading...
Advertisement
News & Literature Highlights
Blood Advances
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Annals of Medicine
Comprehensive analysis of the efficacy and safety of CAR T-cell therapy in patients with relapsed or refractory B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis
Hematology
Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib
Hematology
Procalcitonin level threshold and antibiotic use in patients receiving chimeric antigen receptor T-cell therapy
Blood
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy: A meta-analysis
Blood
Optimizing the post-CAR T monitoring period for axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel
The Lancet
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): An international, open-label, phase 2 trial
Human Vaccines & Immunotherapeutics
Approved CAR-T therapies have reproducible efficacy and safety in clinical practice
New England Journal of Medicine Evidence
CD19 CAR T-cell therapy in autoimmune disease–A case series with follow-up
New England Journal of Medicine Evidence
CAR T-cell immunotherapy in minority patients with lymphoma
Advertisement
Case Studies
Transverse Myelitis With Paraplegia: An Atypical Manifestation of Neurotoxicity Following CAR T-Cell Therapy
CAR T-cell Infusion in an Outpatient Setting: An Ideal Option for Selected Patients When Available
B-Cell Aplasia, Hypogammaglobulinemia Can Result in Serious, Life-Threatening Infections
Fast Facts
Fast Facts #12: BCMA Targets
Advertisement
Quizzes
Test your knowledge of atypical manifestation of neurotoxicity following CAR T-cell therapy
Test your knowledge of CAR T-cell therapy
Test your knowledge of CAR T-cell infusion in an outpatient setting